MRI radiomics for the prediction of recurrence in patients with clinically non-functioning pituitary macroadenomas

被引:33
|
作者
Machado, Leonardo F. [1 ]
Elias, Paula C. L. [3 ]
Moreira, Ayrton C. [3 ]
dos Santos, Antonio C. [4 ]
Murta Junior, Luiz O. [1 ,2 ]
机构
[1] Univ Sao Paulo, Dept Phys, Fac Philosophy Sci & Letters Ribeirao Preto, Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Dept Comp & Math, Fac Philosophy Sci & Letters Ribeirao Preto, Ribeirao Preto, SP, Brazil
[3] Univ Sao Paulo, Clin Hosp, Fac Med Ribeirao Preto, Endocrinol Div, Ribeirao Preto, SP, Brazil
[4] Univ Sao Paulo, Clin Hosp, Fac Med Ribeirao Preto, Endocrinol Div,Ctr Image Sci & Med Phys, Ribeirao Preto, SP, Brazil
关键词
Radiomics; MRI; Pituitary adenoma; Tumor recurrence; Machine learning; TEXTURE ANALYSIS; ADENOMAS; CLASSIFICATION; RADIOTHERAPY; MANAGEMENT; FEATURES; TUMORS; DIAGNOSIS; PATTERN; KI-67;
D O I
10.1016/j.compbiomed.2020.103966
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Twelve to 66% of patients with clinically non-functioning pituitary adenoma (NFPA) experience tumor recurrence 1-5 years after the first surgery. Nevertheless, there is still no recurrence prediction factor concisely established and reproduced in the literature for NFPA management. The present study evaluates the prognostic value of MRI Radiomics features combined with machine learning models to assess recurrence after the first surgery in patients with clinically non-functioning pituitary adenomas (NFPA). We carried out a retrospective study on 27 patients with NFPA, 10 patients having experienced tumor recurrence after the first surgery and 17 who did not. Preoperative 3D T-1 contrast-enhanced MR images of patients were used to extract up to 255 Radiomics features from two and three-dimensional segmented regions. Additionally, gender, age at first surgery, and the presence of remnant tumor tissue were investigated to find the correlation with NFPA recurrence. Conventional statistics tests were used to evaluate whether the outcome patient groups (stable and recurrent) were different considering each feature individually. Additionally, five well-known machine-learning algorithms were used in combination with Radiomic features to classify recurrent and stable lesions. We found statistical evidence (p < 0.02) for 6 two-dimensional and 13 three-dimensional radiomic features. We achieved accuracies of up to 96.3% for 3D-feature based models and up to 92.6% accuracies for 2D-feature based models. 3D-feature based models achieved better performances using considerably fewer features when compared to 2D-feature based models. We concluded that Radiomics have the potential of NFPA recurrence prediction after the first surgery. Three-dimensional Radiomics have superior discrimination power to predict NFPA recurrence than two-dimensional radiomic features. Finally, the combination of Radiomics with machine-learning algorithms can offer computational models capable of non-invasive, unbiased, and quick assessment that might improve the prediction of NFPA recurrence.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Non-functioning pituitary macroadenomas: factors affecting postoperative recurrence, and pre- and post-surgical endocrine and visual function
    Venkatram Subramanian
    Rachel Su Min Lee
    Simon Howell
    Samuel Gregson
    Ian M. Lahart
    Kalpana Kaushal
    Joseph M. Pappachan
    Endocrine, 2021, 73 : 407 - 415
  • [42] Radiomics analysis allows for precise prediction of silent corticotroph adenoma among non-functioning pituitary adenomas
    Wenting Rui
    Nidan Qiao
    Yue Wu
    Yong Zhang
    Ababikere Aili
    Zhaoyun Zhang
    Hongying Ye
    Yongfei Wang
    Yao Zhao
    Zhenwei Yao
    European Radiology, 2022, 32 : 1570 - 1578
  • [43] Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas
    Cannavo, S.
    Ferrau, F.
    Cotta, O. R.
    Saitta, S.
    Barresi, V.
    Cristani, M. T.
    Saija, A.
    Ruggeri, R. M.
    Trimarchi, F.
    Gangemi, S.
    PITUITARY, 2014, 17 (01) : 76 - 80
  • [44] Mortality in patients with non-functioning pituitary adenoma
    Metaxia Tampourlou
    Athanasios Fountas
    Georgia Ntali
    Niki Karavitaki
    Pituitary, 2018, 21 : 203 - 207
  • [45] Mortality in patients with non-functioning pituitary adenoma
    Tampourlou, Metaxia
    Fountas, Athanasios
    Ntali, Georgia
    Karavitaki, Niki
    PITUITARY, 2018, 21 (02) : 203 - 207
  • [46] Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas
    S. Cannavo
    F. Ferrau
    O. R. Cotta
    S. Saitta
    V. Barresi
    M. T. Cristani
    A. Saija
    R. M. Ruggeri
    F. Trimarchi
    S. Gangemi
    Pituitary, 2014, 17 : 76 - 80
  • [47] Management of patients with non-functioning pituitary adenomas
    Köbberling, J
    MEDIZINISCHE KLINIK, 2003, 98 (11) : 616 - 616
  • [48] Correction to: Solid tumor size for prediction of recurrence in large and giant non-functioning pituitary adenomas
    Ching-Chung Ko
    Chin-Hong Chang
    Tai-Yuan Chen
    Sher-Wei Lim
    Te-Chang Wu
    Jeon-Hor Chen
    Yu-Ting Kuo
    Neurosurgical Review, 2022, 45 (2) : 1819 - 1819
  • [49] MiRNA Signatures Related to Invasiveness and Recurrence in Patients With Non-Functioning Pituitary Neuroendocrine Tumors
    Nikolova, Emiliya
    Nankova, Anelia
    Kalenderova, Silvia
    Georgieva, Bilyana
    Hadzhiyanev, Asen
    Bichev, Stoyan
    Savov, Alexey
    Todorova, Albena
    Mitev, Vanyo
    Elenkova, Atanaska
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2024, 132 (05) : 240 - 248
  • [50] Alpha subunit in clinically non-functioning pituitary adenomas: An immunohistochemical study
    Solarski, Michael
    Rotondo, Fabio
    Syro, Luis V.
    Cusimano, Michael D.
    Kovacs, Kalman
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (09) : 1130 - 1133